BeOne Medicines
ONC
#632
Rank
โ‚น3.609 T
Marketcap
โ‚น32,622
Share price
1.19%
Change (1 day)
58.65%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): โ‚น59.27

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น59.11. In 2024 the company made an earnings per share (EPS) of -โ‚น567.48.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น59.27-110.44%
2024-โ‚น567.48
2022-โ‚น1,77328.21%
2021-โ‚น1,383-19.96%
2020-โ‚น1,72820.81%
2019-โ‚น1,43131.52%
2018-โ‚น1,088417.57%
2017-โ‚น210.15-37.16%
2016-โ‚น334.44158.95%
2015-โ‚น129.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น21.83-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น86.39-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA